Breast Cancer: Our Clinical Trials

You may be offered the opportunity to take part in a clinical trial at some point during your treatment. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies that are not yet readily available. Clinical trials may also be used to compare diagnostic tests, prevention strategies, or other aspects of care for cancer patients. Learn more about clinical trials.

Below is a listing of breast cancer clinical trials that are currently enrolling patients at Memorial Sloan-Kettering Cancer Center.

Showing 41 trials
Titlesort icon Investigator
A Feasibility Study of the Effects of a Directed Exercise Program for Breast Cancer Patients Undergoing Chemotherapy with or without Radiation After Axillary Surgery
[Protocol 10-062] 		Heerdt, Alexandra, MD
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
[Protocol 04-101] 		Gilewski, Teresa, MD
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122] 		Fornier, Monica, MD
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer
[Protocol 10-005] 		Chandarlapaty, Sarat, MD, PhD
A Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
[Protocol 10-039] 		Traina, Tiffany, MD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] 		Keohan, Mary, MD
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] 		Schwartz, Gary, MD
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
[Protocol 09-093] 		Modi, Shanu, MD
A Phase IB Study to Assess PTC299 plus Hormonal Therapy in Patients with Metastatic Breast Cancer
[Protocol 09-105] 		Dickler, Maura, MD
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] 		Traina, Tiffany, MD
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063] 		Dickler, Maura, MD
A Phase II Study of Bicalutamide for the Treatment of Androgen-Receptor-Positive, Estrogen- and Progesterone-Receptor-Negative Metastatic Breast Cancer
[Protocol 07-022] 		Traina, Tiffany, MD
A Phase II Study of Carboplatin and/or Bevacizumab Added to Neoadjuvant Paclitaxel Followed by Dose-Dense Doxorubicin/Cyclophosphamide in Triple-Negative Resectable Breast Cancer
[Protocol 10-056] 		Lake, Diana, MD
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190] 		Traina, Tiffany, MD
A Phase II Study of Paclitaxel, Trastuzumab, and Pertuzumab for the Treatment of Metastatic HER2-Positive Breast Cancer
[Protocol 10-142] 		Dang, Chau, MD
A Phase II Study of Partial Breast Irradiation for Select Patients with Early Invasive or Noninvasive Breast Cancer
[Protocol 10-114] 		Powell, Simon, MD
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] 		McCormick, Beryl, MD
A Phase II Study of Tesetaxel as Initial Therapy for Patients with Metastatic Breast Cancer
[Protocol 10-197] 		Seidman, Andrew, MD
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer
[Protocol 05-068] 		McCormick, Beryl, MD
A Phase III Study of Paclitaxel plus Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment for HER2-Positive Breast Cancer
[Protocol 10-076] 		Dang, Chau, MD
A Pilot Study of Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer Scheduled for Mastectomy
[Protocol 11-202] 		McArthur, Heather, MD
A Pilot Study Surveying Female Cancer Patients' Preference for Sexual Health Interventions
[Protocol 10-034] 		Carter, Jeanne, PhD
A Pilot Study to Identify Patient Factors Impacting Adherence to Oral Chemotherapy
[Protocol 11-194] 		Ginex, Pamela, RN, EDD
A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer
[Protocol 09-056] 		King, Tari, MD
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
[Protocol 07-130] 		Ahles, Tim, PhD
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] 		Offit, Kenneth, MD
Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024] 		Disa, Joseph, MD
Clinical Study to Assess Entry of Chemotherapeutic Agents into Brain Metastases in Women with Breast Cancer
[Protocol 09-109] 		Seidman, Andrew, MD
Dual-Energy Contrast-Enhanced Digital Mammography for the Detection and Preoperative Staging of Breast Cancer
[Protocol 10-024] 		Jochelson, Maxine, MD
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
[Protocol 10-104] 		Oeffinger, Kevin, MD
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
[Protocol 10-071] 		Blinder, Victoria, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068] 		Stadler, Zsofia, MD
Evaluating Treatment and Survivorship Care Plans within the LIVESTRONG(TM) Foundation Centers of Excellence Network: Phase II
[Protocol 11-155] 		McCabe, Mary, RN, MA
Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study
[Protocol 06-076] 		Cordeiro, Peter, MD
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
[Protocol 05-058] 		Pusic, Andrea, MD, MHS
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163] 		Chandarlapaty, Sarat, MD, PhD
Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116] 		Roth, Andrew, MD
Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes
[Protocol 10-025] 		Ho, Alice, MD
Rehabilitation of Cognitive Changes in Breast Cancer Survivors
[Protocol 10-105] 		Ryan, Elizabeth, PhD
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079] 		Ahles, Tim, PhD
Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
[Protocol 09-110] 		Castiel, Mercedes, MD
Related Topics
Recommended Links

Clinical Trials

Clinical trials can offer you access to a new, experimental treatment before it is available to most patients. Joining a clinical trial is also a way to make a valuable contribution toward the fight against cancer.